Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Opioid Policy At US FDA: Over-Promising Or Overreacting?
Oct 25 2018
•
By
Michael Cipriano
• Source: Cindy Shebley
More from Legislation
More from Pink Sheet